HIZOF(HIZOF)
HIZOF
No analyst ratings available
No analyst price targets available for HIZOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $648.11B | $684.34B | $713.11B | $773.83B | $817.09B |
| Low | $628.12B | $671.05B | $695.29B | $754.50B | $796.68B |
| High | $668.10B | $697.64B | $730.92B | $793.16B | $837.51B |
| EBITDA Avg | $281.85B | $297.61B | $310.11B | $336.52B | $355.34B |
| Low | $273.15B | $291.82B | $302.37B | $328.11B | $346.46B |
| High | $290.54B | $303.39B | $317.86B | $344.93B | $364.21B |
| EBIT Avg | $272.71B | $287.95B | $300.06B | $325.61B | $343.81B |
| Low | $264.30B | $282.36B | $292.56B | $317.47B | $335.22B |
| High | $281.12B | $293.55B | $307.55B | $333.74B | $352.40B |
| Net Income Avg | $22.02B | $20.12B | $23.59B | $28.96B | $33.08B |
| Low | $21.31B | $19.47B | $22.82B | $28.02B | $32.01B |
| High | $22.74B | $20.78B | $24.36B | $29.90B | $34.16B |
| EPS Avg | $130.90 | $119.61 | $140.22 | $172.13 | $196.65 |
| Low | $126.65 | $115.73 | $135.67 | $166.54 | $190.26 |
| High | $135.15 | $123.50 | $144.78 | $177.72 | $203.04 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $203.50B | $169.29B | $169.59B |
| Low | $203.50B | $169.29B | $169.59B |
| High | $203.50B | $169.29B | $169.59B |
| EBITDA Avg | $88.50B | $73.62B | $73.75B |
| Low | $88.50B | $73.62B | $73.75B |
| High | $88.50B | $73.62B | $73.75B |
| EBIT Avg | $85.63B | $71.23B | $71.36B |
| Low | $85.63B | $71.23B | $71.36B |
| High | $85.63B | $71.23B | $71.36B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |